Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis

Journal of Clinical Rheumatology

Volumn 11, Issue 4, 2005, Pages 213-215

  Jolly, Meenakshi ^a,c   Curran, James J ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Department of Medicine ^*  (United States)

Author keywords

Infliximab; Takayasu arteritis (TA); TNF ; Uveitis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; AORTA ARCH SYNDROME; ARTICLE; BYPASS SURGERY; CASE REPORT; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG MEGADOSE; FEMALE; HUMAN; PRIORITY JOURNAL; REVASCULARIZATION; UVEITIS; VASCULITIS;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; TAKAYASU'S ARTERITIS; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VASCULITIS;

EID: 23644443535     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000173218.28013.3e     Document Type: Article

References (15)

1. Stanford MR, Verity DH. Diagnostic and therapeutic approach to patients with retinal vasculitis. Int Ophthalmol Clin. 2000;40:69-83.
2. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation. 1978;57:27-35:
3. Weiler V, Redtenbacher S, Bancher C, et al. Concurrence of sarcoidosis and aortitis: case report and review of literature. Ann Rheum Dis. 2000;59:850-853.
4. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-929.
5. Smith JR, Rosenbaum JT. Scleritis occurring in association with Takayasu disease. Arch Ophthalmol. 2001;119:778-779.
6. Jain R, Ionides A, Pavesio C, et al. Scleritis as a presenting feature of Takayasu's disease. Br J Ophthalmol. 2000;84:801.
7. Pineda C, Rivera M, Soto ME, et al. Uveitis; a forgotten manifestation of Takayasu arteritis [Abstract]. ACR. 2003.
8. McDonald MA, Ojaimi E, Favilla I. Anterior uveitis in a child with Takayasu's arteritis. Clin Exp Ophthalmol. 2004;32:336-339.
9. Kausman JY, Walker A, Piper S. Acute panuveitis and Takayasu's arteritis. Arch Dis Child. 2003;88:938-939.
10. Santos Lacombe M, Marcos Martin C, Gallardo Galera JM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33:251-255.
11. Sfikakis PP. Behcet's disease: a new target for anti tumor necrosis factor treatment. Ann Rheum Dis. 2002;61(suppl):ii51-ii53.
12. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment resistant uveitis. Arthritis Rheum. 2001;44:1411-1415.
13. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45: 252-257.
14. Sfikakis PP, Theodossiadis PG, Katsiari CG, et al. Effect of infliximab on sight threatening panuveitis in Behcet's disease. Lancet. 2001;358: 295-296.
15. Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu's arteritis. Arthritis Rheum. 2004;50:2296-2304.